Cargando…

Modeling and Molecular Dynamic Simulation of F(ab′)(2) Fragment of Nimotuzumab for Lung Cancer Diagnostics

Lung cancer is one of the leading causes of cancer-related deaths in the world among both men and women. Several studies in the literature report that overexpression and mutation of the epidermal growth factor receptor (EGFR) are implicated in the pathogenesis of some lung cancers. Nimotuzumab is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sastyarina, Yurika, Firdaus, Ade Rizqi Ridwan, Nafisah, Zuhrotun, Hardianto, Ari, Yusuf, Muhammad, Ramli, Martalena, Mutalib, Abdul, Soedjanaatmadja, Ukun MS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842462/ https://www.ncbi.nlm.nih.gov/pubmed/35173422 http://dx.doi.org/10.1177/11779322211002174

Ejemplares similares

Refolding of bioactive human epidermal growth factor from E. coli BL21(DE3) inclusion bodies & evaluations on its in vitro & in vivo bioactivity
por: Maksum, Iman Permana, et al.
Publicado: (2022)

Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates
por: Pradini, Gita Widya, et al.
Publicado: (2020)

Residual Interactions of LL-37 with POPC and POPE:POPG Bilayer Model Studied by All-Atom Molecular Dynamics Simulation
por: Yusuf, Muhammad, et al.
Publicado: (2022)

Nimotuzumab for COVID-19: case series
por: Abdo Cuza, Anselmo A, et al.
Publicado: (2021)

Biosynthesis of Gold and Silver Nanoparticles Using Phytochemical Compounds
por: Zuhrotun, Ade, et al.
Publicado: (2023)

Profile of nimotuzumab in the treatment of high-grade glioma
por: Yang, Qun-ying, et al.
Publicado: (2015)

Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck
por: Crombet Ramos, Tania, et al.
Publicado: (2020)

Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases
por: Hardianto, Ari, et al.
Publicado: (2017)

Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review
por: Parenrengi, Muhammad A, et al.
Publicado: (2022)

Magnetic Molecularly Imprinted Polymers: An Update on Their Use in the Separation of Active Compounds from Natural Products
por: Ariani, Marisa Dwi, et al.
Publicado: (2022)

Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin
por: González Fernández, Sandra, et al.
Publicado: (2022)

Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma
por: Liang, Renba, et al.
Publicado: (2021)

Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab
por: Wang, Yu, et al.
Publicado: (2021)

The Effect of Ethanol on Lipid Nanoparticle Stabilization from a Molecular Dynamics Simulation Perspective
por: Hardianto, Ari, et al.
Publicado: (2023)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
por: Boland, William, et al.
Publicado: (2010)

EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
por: Perez, Rolando, et al.
Publicado: (2011)

Prostate specific antigen change after administration of nimotuzumab in prostate cancer
por: Chaiyasit, Kamon, et al.
Publicado: (2013)

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
por: Li, Zhanzhan, et al.
Publicado: (2017)

Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
por: Huang, Jianfeng, et al.
Publicado: (2018)

Time profile of nimotuzumab for enhancing radiosensitivity of the Eca109 cell line
por: Li, Jiancheng, et al.
Publicado: (2019)

Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment
por: Londres, Henrry Diaz, et al.
Publicado: (2022)

An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC
por: Huang, Yanping, et al.
Publicado: (2023)

Pharmacological Activities of Soursop (Annona muricata Lin.)
por: Mutakin, Mutakin, et al.
Publicado: (2022)

Callyspongia spp.: Secondary Metabolites, Pharmacological Activities, and Mechanisms
por: Hadisaputri, Yuni Elsa, et al.
Publicado: (2023)

Caspase Cascade Activation During Apoptotic Cell Death of Human Lung Carcinoma Cells A549 Induced by Marine Sponge Callyspongia aerizusa
por: Hadisaputri, Yuni Elsa, et al.
Publicado: (2021)

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
por: Diaz-Miqueli, Arlhee, et al.
Publicado: (2013)

Use of nimotuzumab in the patient with G-6-PD deficiency: The first world report
por: Wiwanitkit, Viroj
Publicado: (2013)

Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model
por: Bhuvaneswari, Ramaswamy, et al.
Publicado: (2015)

Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma
por: Fei, Zhaodong, et al.
Publicado: (2020)

Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Thai Hoa, Nguyen Thi, et al.
Publicado: (2020)

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
por: Song, Xinmao, et al.
Publicado: (2019)

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma
por: Zong, Jing-Feng, et al.
Publicado: (2021)

Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Evaluation of nimotuzumab Fab(2) as an optical imaging agent in EGFR positive cancers
por: Bernhard, Wendy, et al.
Publicado: (2023)

Prophylactic Efficacy of Equine Immunoglobulin F(ab′)(2) Fragments Against Feline Parvovirus
por: Liu, Jinfeng, et al.
Publicado: (2021)

The Relationship of Health Beliefs on the Stage of Mammography Behavior Adoption amongst Women in Kuantan, Pahang
por: Aisyah Ramli, Hanis, et al.
Publicado: (2019)

Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial
por: Yuan, Jing-Jing, et al.
Publicado: (2022)

Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G
por: Nasiri, Hadi, et al.
Publicado: (2017)

Equine immunoglobulin F(ab')(2) fragments protect cats against feline calicivirus infection
por: Cui, Zhanding, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_itimdnjlidv4qf452majl3ades